Biobot Surgical’s Mona Lisa 2.0 Receives CE Certification for Advanced Prostate Care
Biobot Surgical has announced the CE Certification of its Mona Lisa 2.0 system, marking a significant advancement in the treatment of prostate diseases. This certification complements existing approvals from the US FDA, Australia TGA, and Singapore HSA, extending Mona Lisa 2.0’s availability to urologists in over 32 countries. The system is designed to optimize prostate biopsies and ablations, integrating cutting-edge technology to enhance patient outcomes significantly.
Mona Lisa 2.0 stands out for its precise interventional capabilities. It features advanced positioning systems that allow real-time adjustments to the prostate model and needle paths, accommodating intra-procedural shifts and enhancing the accuracy of both diagnostic and therapeutic interventions. This precision ensures effective treatment outcomes even in complex clinical scenarios. Additionally, the system’s new software includes needle deflection adjustment, further enhancing needle accuracy by compensating for variations caused by tissue heterogeneity or needle tip design.
The system’s streamlined multi-needle insertions and optimized visualization capabilities also significantly improve procedural efficiency. These features reduce manual effort and enhance the workflow, allowing urologists to perform complex interventions with greater ease and precision. The visual overlays of lesion margins and simulated ablation zones assist in accurately targeting areas of interest while preserving critical structures.
Albert Lee, CEO of Biobot Surgical, emphasized the impact of the CE Certification: “Mona Lisa 2.0 is poised to transform prostate care in Europe. Its unparalleled precision and adaptability allow urologists to achieve superior patient outcomes.” With over 25,000 global cases already performed using the Mona Lisa Platform, this next-generation system is set to revolutionize European urology practices, ensuring enhanced care quality and operational efficiency for healthcare providers.
